Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,545 across all filing types
Latest filing 2023-02-23 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice x 8 28 pages 398.3KB
Regulatory Filings
2023-02-23 English
Portfolio Update 1 page 313.0KB
Regulatory Filings
2023-02-20 English
CSL Statutory Accounts for the Half Year Ended 31 Dec 2022 28 pages 919.9KB
Regulatory Filings
2023-02-13 English
CSL Half Year Results Announcement & Investor Presentation 30 pages 2.3MB
Regulatory Filings
2023-02-13 English
Dividend/Distribution - CSL 5 pages 27.6KB
Regulatory Filings
2023-02-13 English
Notification of cessation of securities - CSL 4 pages 24.1KB
Regulatory Filings
2023-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.